Your browser doesn't support javascript.
loading
Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution.
Rocanières, Pierre; Lamure, Sylvain; Geny, Christian; Hillaire-Buys, Dominique; Faillie, Jean-Luc; Bres, Virginie.
Affiliation
  • Rocanières P; Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Centre, CHU Montpellier, Montpellier, France.
  • Lamure S; Department of Clinical Hematology, CHU Montpellier, IGMM UMR5535 CNRS, Univ Montpellier, Montpellier, France.
  • Geny C; Department of Internal Medicine and Geriatrics, CHU Montpellier, Montpellier, France.
  • Hillaire-Buys D; Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Centre, CHU Montpellier, Montpellier, France.
  • Faillie JL; Department of Medical Pharmacology and Toxicology, Pharmacovigilance Regional Centre, CHU Montpellier, Montpellier, France.
  • Bres V; Desbrest Institute of Epidemiology and Public Health, Univ Montpellier, INSERM, Montpellier, France.
J Parkinsons Dis ; 12(8): 2601-2603, 2022.
Article in En | MEDLINE | ID: mdl-36189606
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Multiple Myeloma Limits: Humans Language: En Journal: J Parkinsons Dis Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Multiple Myeloma Limits: Humans Language: En Journal: J Parkinsons Dis Year: 2022 Document type: Article Affiliation country: